https://consultqd.clevelandclinic.org/car-t-cell-therapy-with-axicabtagene-ciloleucel
CAR T-Cell Therapy with Axicabtagene Ciloleucel
ZUMA-7 trial yields practice-changing findings for patients with large B-cell lymphoma who relapse on first-line chemoimmunotherapy.
car t cell therapy
https://pubmed.ncbi.nlm.nih.gov/34895487/
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a...
Kite, a Gilead Company.
non hodgkin lymphoma
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.768128/full
Frontiers | Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel,...
Corrigendum on: Meng J, Wu X, Sun Z, Xun R, Liu M, Hu R and Huang J (2021) Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleuc...
efficacy and safety